Bangying Su
Corporate Officer/Principal en Washington University in St. Louis .
Perfil
Bangying Su is currently a Principal at Washington University in St. Louis and a Principal at The University of Alabama.
Previously, Dr. Su worked as a Scientist at Dynamis Therapeutics, Inc. Dr. Su completed their undergraduate degree at Peking University.
Cargos activos de Bangying Su
| Empresas | Cargo | Inicio |
|---|---|---|
| Washington University in St. Louis | Corporate Officer/Principal | 25/01/2010 |
| The University of Alabama | Corporate Officer/Principal | 25/01/2010 |
Antiguos cargos conocidos de Bangying Su.
| Empresas | Cargo | Fin |
|---|---|---|
Dynamis Therapeutics, Inc.
 Dynamis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA. | Corporate Officer/Principal | - |
Formación de Bangying Su.
| Peking University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Dynamis Therapeutics, Inc.
Dynamis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dynamis Therapeutics, Inc. operates as a holding company with interests in developing pharmaceuticals and diagnostics. It operates through its subsidiaries Dynamis Pharmaceuticals, Inc. and Dynamis Skin Science. The firm's product DYN 15, a drug candidate that prevents the formation of 3DG, a reactive sugar, as well as decreases the levels of key cytokines that are stimulated in chronic inflammations. The company was founded by Annette M. Tobia on May 21, 1997 and is headquartered in Jenkintown, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Bangying Su
